| Ex. DUT-FED-007 | 29 C.F.R. 1910.1030 (bloodborne pathogens)Bloodborne pathogens | Occupational Safety and Health Administration | United StatesFederal | Dec. 6, 1991 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Standing dutyHealth care ordersWorkplace rulesStanding duty | Primary source read | |
| Ex. DUT-FED-004 | 29 C.F.R. 1910.134 (respiratory protection)Respiratory protection | Occupational Safety and Health Administration | United StatesFederal | Jan. 8, 1998 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Standing dutyHealth care ordersWorkplace rulesStanding duty | Primary source read | |
| Ex. AGY-DEFENSE-GUARD-026 | Force Health Protection Guidance for the Novel Coronavirus Outbreak (Jan. 30, 2020)Force Health Protection Guidance for the Novel Coronavirus Outbreak | Under Secretary of Defense for Personnel and Readiness (Matthew P. Donovan) | Department of Defense (department-wide)Federal | Jan. 30, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Emergency declarationHealth care ordersQuarantine and isolation | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-038 | Determination of Public Health Emergency and Declaration that circumstances exist justifying emergency use of in vitro diagnostics, 85 Fed. Reg. 7316 (Feb. 7, 2020)Determination of Public Health Emergency | Alex M. Azar II, Secretary of Health and Human Services | United States (federal); Department of Health and Human Services, Office of the SecretaryFederal | Feb. 4, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Emergency declarationSupply chain | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-040 | Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (Mar. 17, 2020)Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19 | Alex M. Azar II, Secretary of Health and Human Services | United States (federal); Department of Health and Human Services, Office of the SecretaryFederal | Mar. 10, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Emergency declarationHealth care ordersOther | Primary source read | |
| Ex. FED-180 | Declaration Under the PREP Act for Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (Mar. 17, 2020; effective Feb. 4, 2020)Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (Mar.… | Secretary of Health and Human Services | United StatesFederal | Mar. 10, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Emergency declarationHealth care orders | Primary source read | |
| Ex. FED-181 | Determination of Public Health Emergency and Declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for 2019-nCoVDetermination of Public Health Emergency, 85 Fed. Reg. 7316 (Feb. 7, 2020) | Secretary of Health and Human Services | United StatesFederal | Feb. 4, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Emergency declarationHealth care orders | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-032 | Policy for Diagnostics Testing in Laboratories Certified To Perform High Complexity Testing Under CLIA Prior to Emergency Use Authorization for Coronavirus Disease-2019 During the Public Health Emergency; Immediately in Effect Guidance, 85 Fed. Reg. 13138 (Mar. 6, 2020)Policy for Diagnostics Testing in Laboratories Certified To Perform High Complexity Testing Under the Clinical Laboratory Improvement… | Food and Drug Administration, HHS | United States (federal); Food and Drug AdministrationFederal | Feb. 29, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersOther | Primary source read | |
| Ex. FED-160 | COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers (consolidated document; version updated May 24, 2021)COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers | Centers for Medicare & Medicaid Services, HHS | United States (Medicare, Medicaid and CHIP providers)Federal | Mar. 13, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersOther | Primary source read | |
| Ex. SEC-01-010 | COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers (hospitals: Hospitals Without Walls; EMTALA; verbal orders; discharge planning; medical staff; physical environment; surge sites)COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers (Updated 5/24/21) | CMS | United StatesFederal | Mar. 30, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care orders | Primary source read | |
| Ex. SEC-02-005 | COVID-19 Emergency Declaration Blanket Waivers for Health Care ProvidersBlanket 1135 waivers (physicians and other clinicians: telehealth, licensure, supervision, signature, enrollment) | CMS (Secretary of HHS) | United StatesFederal | Mar. 30, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersOther | Primary source read | |
| Ex. SEC-04-015 | COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers (LTC facilities, HHAs, hospices, ICF/IIDs)COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers | Centers for Medicare & Medicaid Services (section 1135 waiver authority) | United StatesFederal | Mar. 30, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersWorkplace rulesOther | Primary source read | |
| Ex. SEC-04-017 | CMS-1744-IFC, 85 Fed. Reg. 19230Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency | Centers for Medicare & Medicaid Services | United StatesFederal | Apr. 6, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-039 | Emergency Use Declaration (personal respiratory protective devices), 85 Fed. Reg. 13907 (Mar. 10, 2020)Emergency Use Declaration | Alex M. Azar II, Secretary of Health and Human Services | United States (federal); Department of Health and Human Services, Office of the SecretaryFederal | Mar. 2, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Emergency declarationSupply chain | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-052 | Emergency Use Authorization: NIOSH-approved air purifying respirators for health care personnel (issued Mar. 2, 2020; reissued Mar. 28, 2020 and July 12, 2021)Letter of Authorization to CDC, NIOSH-Approved Air Purifying Respirators (reissued July 12, 2021) | Jacqueline A. O'Shaughnessy, Acting Chief Scientist, FDA (letter to CDC) | United States (federal); Food and Drug AdministrationFederal | July 12, 2021 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersSupply chain | Primary source read | |
| Ex. FED-182 | Emergency Use Declaration: personal respiratory protective devicesEmergency Use Declaration, 85 Fed. Reg. 13907 (Mar. 10, 2020) | Secretary of Health and Human Services | United StatesFederal | Mar. 2, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Emergency declarationSupply chain | Primary source read | |
| Ex. FED-096 | CMS QSO-20-13-Hospitals (Mar. 4, 2020), QSO-20-14-NH (Mar. 13, 2020), QSO-20-18-HHA (Mar. 10, 2020)QSO-20-13-Hospitals | CMS, Center for Clinical Standards and Quality / Quality, Safety & Oversight Group | United States (Medicare-participating hospitals)Federal | Mar. 4, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care orders | Primary source read | |
| Ex. SEC-01-006 | QSO-20-13-Hospitals-CAHs (REVISED)Guidance for Infection Control and Prevention Concerning Coronavirus Disease (COVID-19): FAQs and Considerations for Patient Triage… | CMS, Quality, Safety & Oversight Group | United StatesFederal | Mar. 4, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care orders | Confirmed from a secondary source | |
| Ex. SEC-04-078 | Appendix K: Emergency Preparedness and Response and COVID-19 Addendum to the Community HealthChoices and OBRA 1915(c) waivers (combined; final amendment fixing the end date)Appendix K: Emergency Preparedness and Response | Centers for Medicare & Medicaid Services (approval) on the application of the Pennsylvania Department of Human Services, Office of Long-Term Living | Pennsylvania Medicaid (Community HealthChoices waiver PA.0386 and OBRA waiver PA.0235), as the exemplar of every State's Appendix KFederal | Mar. 6, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersWorkplace rulesOther | Primary source read | |
| Ex. FED-098 | QSO-20-18-HHA, Guidance for Infection Control and Prevention Concerning Coronavirus Disease 2019 (COVID-19) in Home Health Agencies (HHAs)QSO-20-18-HHA | CMS, Quality, Safety & Oversight Group | United States (Medicare and Medicaid home health agencies)Federal | Mar. 10, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care orders | Primary source read | |
| Ex. DUT-FED-065 | Emergency Declaration Under 49 CFR § 390.23 No. 2020-002 (Mar. 13, 2020)Emergency Declaration Under 49 CFR § 390.23 No. 2020-002 | Federal Motor Carrier Safety Administration | United StatesFederal | Mar. 13, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Standing dutyTravel and quarantineWorkplace rulesSupply chain | Primary source read | |
| Ex. AGY-FED-LABOR-IMMIGRATION-015 | Memorandum, Temporary Enforcement Guidance - Healthcare Respiratory Protection Annual Fit-Testing for N95 Filtering Facepieces During the COVID-19 Outbreak (Mar. 14, 2020)Temporary Enforcement Guidance - Healthcare Respiratory Protection Annual Fit-Testing for N95 Filtering Facepieces During the COVID-19… | OSHA, Directorate of Enforcement Programs (Patrick J. Kapust, Acting Director), to Regional Administrators and State Plan Designees | United States Department of Labor, Occupational Safety and Health Administration (federal agency)Federal | Mar. 14, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q2 | Health care ordersWorkplace rulesSupply chain | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-008 | DEA-DC-015, Exception to 21 C.F.R. 1301.74(h) for Narcotic Treatment Programs (take-home delivery by NTP staff, law enforcement or National Guard)SAMHSA Exemption - NTP Deliveries (Coronavirus) | Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA (letter to Assistant Secretary Elinore McCance-Katz, SAMHSA) | United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal | Mar. 16, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-009 | DEA-DC-016, COVID-19 Information Page: Telemedicine (designation that the section 802(54)(D) telemedicine allowance applies to all schedule II-V controlled substances in all areas of the United States)Use of Telemedicine While Providing Medication Assisted Treatment / COVID-19 Telemedicine (updated) | Drug Enforcement Administration, Diversion Control Division (with the HHS Secretary's designation of Mar. 16, 2020) | United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal | Mar. 16, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Telework mandateHealth care ordersOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-026 | Opioid Treatment Program (OTP) Guidance (Mar. 16, 2020; updated Mar. 19, 2020): blanket take-home exceptionsOpioid Treatment Program (OTP) Guidance | SAMHSA (Assistant Secretary for Mental Health and Substance Use) | United States (federal); Substance Abuse and Mental Health Services AdministrationFederal | Mar. 16, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersOther | Primary source read | |